References
- Anonymous (2001). Biomarker definition working group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89-95.
- Akalin, E., Dinavahi, R., Friedlander, R., Ames, S., de Boccardo, G., Sehgal, V., Schroppel, B., Bhaskaran, M., Lerner, S., Fotino, M., Murphy, B., Bromberg, J. S. (2008). Addition of plasmapheresis decreased the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin. J. Amer. Soc. Nephrol., 3, 1160-1167.
- Anglicheau, D., Suthanthiran, M. (2008). Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation, 86, 192-199.
- Banon-Maneus, E., Diekmann, F., Carrascal, M., Quintana, L.F., Moya-Rull, D., Bescos, M., Ramírez-Bajo, M. J., Rovira, J., Gutierrez-Dalmau, A., Sole-Gonzalez, A., Abian, J., Campistol, J. M. (2010). Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers. Transplantation, 89, 548-558.
- Bestard, O., Gruzado, J., Cassis, L., Franquesa, M., Cantarelli, C., Torras, J., Goma, M., Sawitzki, B., Volk, H., Reinke, P., Grinyo, J. (2011). Immune- monitoring of alloreactive memory/effector T-cell alloresponse for selection on CNI-free immunpsupression in renal transplantation. Amer. J. Transplant., 11, 395.
- Borozdenkova, S., Westbrook, J. A., Patel, V., Wait, R., Bolad, I., Burke, M. M., Bell, A. D., Banner, N. R., Dunn, M. J., Rose, M. L. (2004). Use of proteomics to discover novel markers of cardiac allograft rejection. J. Proteome Res., 3, 282-287.
- Brouard, S., Mansfield, E., Braud, C., Li, L., Giral, M., Hsieh, S. C., Baeten, D., Zhang, M., Ashton-Chess, J., Braudeau, C., Hsieh, F., Dupont, A., Pallier, A., Moreau, A., Louis, S., Ruiz, C., Salvatierra, O., Soulillou, J. P., Sarwal, M. (2007). Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc. Nat. Acad. Sci USA., 104, 15448-15453.
- Calabuig, A., Guirado, L., Ramos, D. (2012). Prognostic significance and diagnosis of proteinuria in renal transplantation. Transplant. Rev., 26, 30-35.
- Coca, S., Yalavarthy, R., Concato, J., Parikh, C. (2008). Biomarkers for the diagnosis and risk stratification of acute kidney injury. A systematic review. Kidney Int., 73, 1008-1016.
- Danovitch, G. (2010). Handbook of Kidney Transplantation, 5th edition. Lippincott: Williams and Wilkins. 471 pp.
- De Gruttola, V. G. (2001). Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of the National Institutes of Health workshop. Control Clin. Trials, 22, 485-502.
- Einecke, G., Mengel, M., Reeve, J., Gwinner, W., Broecker, V., Haller, H., Halloran P.F. (2010). Molecular changes in renal allograft protocol biopsies reflect a stereotyped organization in injured or inflamed sites. Amer. J. Transplant., 10 (Suppl 4), 62.
- Farid, W., Pan, Q., van der Meer, A. (2011). Hepatocyte-derived microRNA in human serum are sensitive markers for hepatic injury in liver transplantation. Amer. J. Transplant., 11 (Suppl 2), 389.
- Flechner, S. M., Kurian, S. M., Head, S. R., Sharp, S. M., Whisenant, T. C., Zhang, J., Chismar, J. D., Horvath, S., Mondala, T., Gilmartin, T., Cook, D.J., Kay, S. A., Walker, J. R., Salomon, D. R. (2004). Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Amer. J. Transplant., 4, 1475-1489.
- Foster, C., Cooper, C. (2009). Urgent need develop independent biomarkers for functional, diagnostic and prognostic application in oncology research. Biomarkers Med., 3, 329-333.
- Gillespie, A., Lee, I. (2008). Biomarkers in renal transplantation. BiomarkersMed., 2, 603-612.
- Graetz, K., Inston, N., Rigg, K. (2009). The donor procedure. In: Transplantation,4th edition. Forsythe, J. (ed.). Saunders Ltd., Edinburgh, pp. 101-124.
- Halloran, Ph. (2010). Individualizing immunosuppressive therapy: Opportunities to manage risk. Amer. J. Transplant., 10 (Suppl.1), 48.
- Henderson, L., Nankivell, B., Chapman, J. (2011). Surveillance protocol kidney transplant biopsies: Their evolving role in clinical practice. Amer. J. Transplant.,11, 1570-1575.
- Ho, J., Rush, D., Karpinsky, M., Storsley, L., Gibson, J., Stefura, W., Hayglass, K., Nickerson, P. (2010) Urinary MCP1 at 6 month correlates with development of interstitial fibrosis and tubular atrophy at 24 month in renal allograft. Amer. J. Transplant., 10 (Suppl 4): 60.
- Ho, J., Rush, D., Bestland, J., Gao, A., Karpinsky, M., Storsley, L., Gibson, J., Nickerson, P. (2011). Validation of urinary CXCL10 as a maker of borderline, subclinical and clinical tubulitis. Amer. J. Transplant., 11 (Suppl 2), 387.
- Hollmen, M., Kyllonen, L., Inkenen, K., Lalla, M. L., Salmela, K. T. (2011). Urine neutrophil gelatinase associated lipokalin is a marker of graft recovery after kidney transplantation. Kidney Int., 79, 89-98.
- Hricik, D. (2011). Primer on Transplantation, 3rd edition. Blackwell, West Sussex: Wiley. 307 pp.
- Johnson, M., Kao, W., Winkel, E. (2011). Heart transplantation. In: Primeron Transplantation, 3rd edition. Hricik, D. (ed.). Wiley-Blackwell, West Sussex, pp. 171-204.
- Jahnukainen, T., Malehorn, D., Sun, M., Lyons-Weiler, J., Bigbee, W., Gupta, G., Shapiro, R., Randhawa, P. S., Pelikan, R., Hauskrecht, M., Vats, A. (2006). Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy. J. Amer. Soc. Nephrol., 17, 3248-3252.
- Jushinskis, J., Amerika, D., Suhorukovs, V., Trushkovs, S., Maltsevs, A., Rozental, R. (2011). Urine NGAL as a biomarker for evaluation of deceased kidney donors. Transplant. Int., 24, 273.
- Klienzl-Wagner, K., Pratschke, J., Brandacher, G. (2011). Proteomics- a blessing or curse? Application of proteomics technology to transplant medicine. Transplantation, 92, 499-509.
- Loupy, A., Hill, G., Suberbielle, C., Charron, D., Anglicheau, D., Zuber, J., Timsit, M., Bruneval, P., Empans, J., Jouven, X., Legendre, C. (2011).. Significance of CD4 Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Amer. J. Transplant., 11, 56-65.
- Matar, M., Nguyen, M., Aljiffry, M., Salman, A., Aikins, R., Paraskevas, S. (2011). HMGB-1 and HSP-70 in mechanically preserved kidney allograft as markers of long term function. Amer. J. Transplant., 11 (Suppl 2), 383-384.
- Mba, M., Maluf, D., Dumer, S., Scian, M., Posner, M., King, A., Gehr, B., Cotterell, A., Mas, R. (2011). Molecular biomarkers of human kidney transplant ischemia reperfusion injury. Amer. J. Transplant., 11 (Suppl 2), 454.
- McIlroy, D., Wagener, G., Lee, H. (2010). Biomarkers in acute kidney injury: An evolving domain. Anesthesiology, 112, 998-1004.
- Molnar, M., Kovesdy, C., Bunnapradist, S., Streja, E., Krishnan, M., Nisselson, A., Kalantar-Zadeh, K. (2011). Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Amer. J. Transplant., 11, 1006-1016.
- Mueller, T., Pedrycz, B., Comtson, C., Zhu, L., Andeson, C., Perkins, D., Luyckx, V. (2011). Oncostatin M and its receptors are key mediator of local and distant organ inflammation and injury after ischemia and reperfusion. Amer. J. Transplant., 11 (Suppl 2), 389.
- Muthukumar, T., Mueller, F., Anglicheau, D., Sharma, V., Ding, R., Suthanthiran, M. (2011). Intragraft MicroRNA expression signatures of interstitial fibrosis and tubular atrophy of human renal allografts. Amer. J. Transplant., 10, 291.
- Nankivell, B. J., Chapmen, J. R. (2006). Chronic allograft nephropathy. Current concept and future direction. Transplantation, 81, 643-654.
- Nickel, P., Presber, F., Bold, G., Biti, D., Schonemann, C., Tullius, S. G., Volk, H. D., Reinke, P. (2004). Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells indentifies T-cell presentation and correlates with graft function at 6 at 12 month in renal- transplant recipients. Transplantation, 78, 1640-1646.
- Parikh, C., Jani, A., Mishra, J., Ma, Q., Kelly, C., Barasch, J., Edelstein, C. L., Devarajan, P. (2006). Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Amer. J. Transplant., 6, 1639-1645.
- Quintana, L. F., Sole-Gonzalez, A., Kalko, S. G., Banon-Maneus, E., Sole, M., Diekmann, F., Gutierrez-Dalmau, A., Abian, J., Campistol, J. M. (2009). Urine proteomics to detect biomarkers for chronic allograft dysfunction. J. Amer. Soc. Nephrol., 20, 428-435.
- Reeve, J., Einecke, G., Mengel, M., Sis, B., Kayser, N., Kaplan, B., Halloran, P. (2009). Diagnosing rejection in renal transplants: A comparison of molecular and histopathology-based approaches. Amer. J. Transplant., 9, 180-1810.
- Roukos, D. (2010) Next generation, genome sequencing based biomarkers: Concerns and challenges for medical practice. Biomarkers Med., 4, 583-586.
- Sagoo, P., Perucha, E., Sawitzki, B., Tomiuk, S., Stephens, D. A., Miqueu, P., Chapman, S., Craciun, L., Sergeant, R., Brouard, S., Rovis, F., Jimenez, E., Ballow, A., Giral, M., Rebollo-Mesa, I., Le Moine, A., Braudeau, C., Hilton, R., Gerstmayer, B., Bourcier, K., Sharif, A., Krajewska, M., Lord, G. M., Roberts, I., Goldman, M., Wood, K. J., Newell, K., Seyfert-Margolis, V., Warrens, A. N., Janssen, U., Volk, H. D., Soulillou, J. P., Hernandez-Fuentes, M. P., Lechler, R. I. (2010). Development of a crossplatform biomarker signature to detect renal transplant tolerance in humans. J. Clin. Invest., 120, 1848-1861.
- Shand, J. A., Menown, I. B., McEneaney, D. J. (2010). A timely diagnosis of myocardial infarction. Biomarkers Med. ,4, 385-393.
- Snanoudj, R., Royal, V., Elie, C., Rabant, M., Girardin, C., Morelon, E., Kreis, H., Fournet, J. C., Noel, L. H., Legendre, C. (2011). Specificity of histological markers of long term CNI nephrotoxicity in kidney transplant recipient under low-dose cyclosporine therapy. Amer. J. Transplant., 11, 2635-2646.
- Sprangers, B., Kuypers, D., Vanrenterghem, Y. (2011). Immunosupression: Does one regimen fit all. Transplantation, 93, 251-261.
- Stock, P., Kirk, A. (2011). The risk and opportunity of homeostasis repopulation. Amer. J. Transplant., 11, 1349-1350.
- Suthanthiran, M., Ding, R., Sharma, V., Abecassis, M., Samstein, B., Knechtle, S., Hascock, W., Han, L., Liu, J., Shaked, A. (2011). Urinary cell messenger RNA expression signatures anticipate acute cellular rejection. Amer. J. Transplant., 11 (Suppl 2), 29.
- Tyres, M., Mann, M. (2006). From genomics to proteomics. Nature, 422, 193-196.
- Vasan, R. S. (2006). Biomarkers of cardiovascular disease: Molecular basis and practical considerations. Circulation, 113, 2335-2362.
- Waikar, S., Betensky, R., Emerson, S., Bonventre, J. (2012). Imperfect gold standards for kidney injury biomarker evolution. J. Amer. Soc. Nephrol., 23, 13-21.
- Waldman, S., Terzic, A. (2011). Patient-centric clinical pharmacology advances the path to personalized medicine. Biomarkers Med., 5, 607-700.
- Zou, Y., Stastny, P., Susal, C., Dohler, B., Opelz, G. (2007). Antibodies against MICA antigens and kidney-transplant rejection. New Engl. J. Med., 357, 1293-1300.